Claritev Corporation
CTEV
Rank in Stocks
#13222
Claritev Corporation, together with its affiliated companies, provides advanced... Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
Share Price
$24.00
Last synced: 2026-11-09
Market Cap
$406.74M
Change (1 day)
5.68%
Change (1 year)
-58.08%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Claritev Corporation (CTEV)
Category
Healthcare
EPS for Claritev Corporation (CTEV)
EPS as of June 2026 TTM: $-17.01
According to Claritev Corporation's latest financial reports, its current EPS (TTM) is $-17.01. At the end of 2025 the company had an EPS of $-17.30, an increase over its 2024 EPS of $-101.92.
EPS history for Claritev Corporation from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-17.01 | -1.68% |
| 2025 | $-17.30 | -83.03% |
| 2024 | $-101.92 | 1,691.21% |
| 2023 | $-5.69 | -84.14% |
| 2022 | $-35.87 | -660.47% |
| 2021 | $6.40 | -114.47% |
| 2020 | $-44.23 | -12,737.14% |
| 2019 | $0.35 | -73.48% |
| 2018 | $1.32 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | -122.69% |
US
|
|
| $-1.05 | -93.83% |
US
|
|
| $1.79 | -110.54% |
AU
|
|
| $1.64 | -109.64% |
US
|
|
| $2.08 | -112.23% |
US
|
Questions about Claritev Corporation's earnings per share (EPS)
What is Claritev Corporation's earnings per share (EPS)?
Claritev Corporation's earnings per share (EPS) over the last twelve months is $-17.01, as of Jun 2026.
What was Claritev Corporation's earnings per share (EPS) in 2025?
In 2025, Claritev Corporation's earnings per share (EPS) was $-17.30, compared with $-101.92 in 2024.
How has Claritev Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Claritev Corporation's earnings per share (EPS) was highest in 2021 ($6.40) and lowest in 2024 ($-101.92).
How does Claritev Corporation's earnings per share (EPS) compare with similar companies?
Claritev Corporation's earnings per share (EPS) ($-17.01) is lower than that of all 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.